A detailed history of California State Teachers Retirement System transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 1,830 shares of FHTX stock, worth $14,768. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,830
Previous 2,044 10.47%
Holding current value
$14,768
Previous $13,000 23.08%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$5.05 - $8.0 $1,080 - $1,712
-214 Reduced 10.47%
1,830 $10,000
Q1 2024

May 15, 2024

SELL
$2.82 - $7.94 $3,671 - $10,337
-1,302 Reduced 38.91%
2,044 $13,000
Q4 2023

Feb 13, 2024

SELL
$2.94 - $6.76 $3,348 - $7,699
-1,139 Reduced 25.4%
3,346 $21,000
Q3 2023

Nov 14, 2023

SELL
$5.0 - $9.87 $11,385 - $22,473
-2,277 Reduced 33.67%
4,485 $22,000
Q2 2023

Aug 21, 2023

SELL
$5.37 - $8.84 $3,807 - $6,267
-709 Reduced 9.49%
6,762 $47,000
Q1 2023

May 09, 2023

SELL
$4.66 - $8.99 $2,567 - $4,953
-551 Reduced 6.87%
7,471 $46,000
Q4 2022

Feb 14, 2023

BUY
$5.44 - $9.46 $489 - $851
90 Added 1.13%
8,022 $51,000
Q3 2022

Nov 18, 2022

SELL
$7.52 - $18.01 $4,970 - $11,904
-661 Reduced 7.69%
7,932 $68,000
Q2 2022

Aug 15, 2022

BUY
$8.48 - $16.84 $2,043 - $4,058
241 Added 2.89%
8,593 $117,000
Q1 2022

May 16, 2022

SELL
$8.87 - $22.1 $20,897 - $52,067
-2,356 Reduced 22.0%
8,352 $127,000
Q4 2021

Feb 15, 2022

SELL
$10.79 - $22.87 $7,153 - $15,162
-663 Reduced 5.83%
10,708 $245,000
Q3 2021

Nov 15, 2021

SELL
$8.33 - $15.02 $129,997 - $234,402
-15,606 Reduced 57.85%
11,371 $158,000
Q2 2021

Aug 16, 2021

BUY
$9.32 - $13.26 $150,042 - $213,472
16,099 Added 148.0%
26,977 $288,000
Q4 2020

Feb 16, 2021

BUY
$15.12 - $25.88 $164,475 - $281,522
10,878 New
10,878 $220,000

Others Institutions Holding FHTX

About Foghorn Therapeutics Inc.


  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $336M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.